Osteopathic manifesto. VIII. our distinct image. 1981
Northup, G.W.; Northup, G.W.
Journal of the American Osteopathic Association 97(8): 452
1997
ISSN/ISBN: 0098-6151 PMID: 9424464 Document Number: 471910
Document emailed within 1 workday
Related Documents
Sgreccia, E. 2000: Un manifesto di biopolitica : per una nuova democrazia - A biopolitics manifesto : for a new democracy Medicina e Morale 50(4): 631-633Mahasandana, C.; Suvatte, V.; Püng-amritt, P.; Tuchinda, S. 1979: Von Willebrand's disease: studies of platelet functions, factor VIII procoagulant activity (F VIII C) and factor VIII-related antigen (F VIII RAg) in three families Southeast Asian Journal of Tropical Medicine and Public Health 10(2): 243-247
Ching, L.Mae-Geen.; Burke, W.J. 2011: Osteopathic distinctiveness in osteopathic predoctoral education and its effect on osteopathic graduate medical education Journal of the American Osteopathic Association 111(10): 581-584
Lemley, W.W.; Steele, K.M.; Shires, W.E.; McMahan, R.M. 2007: Evolution of osteopathic graduate medical education: integration of osteopathic principles and practice in postdoctoral training Journal of the American Osteopathic Association 107(11): 495-501
Northup, G.W. 1975: History of the development of osteopathic concepts, with notes on osteopathic terminology Journal of the American Osteopathic Association 75(4): 405-409
Tran, T.H.; Duckert, F. 1983: Dissociation of factor VIIi procoagulant antigen VIII:CAg and factor VIIi related antigen VIIIR:Ag by EDTA - influence of divalent cation on the binding of VIII:CAg and VIIIR:Ag Thrombosis and Haemostasis 50(2): 547-551
Adiego, M.I.; Luetje, C.M.; Valles, H.; Thedinger, B.S. 1999: An analysis of the tumor growth rate in neuroma of the VIIi cranial nerve using a digital image analysis system Acta Otorrinolaringologica Espanola 50(6): 427-431
Brown, J.E.; Carton, C.L.; Hougie, C. 1981: The effect of naturally occurring antibodies to factor VIIi on an immunoradiometric assay for factor VIIi coagulant antigen. Observation on a cross-reacting material-positive (CRM+) hemophiliac with a factor VIIi inhibit Journal of Laboratory and Clinical Medicine 97(1): 65-71
Takahashi, I.; Furuta, M.; Mizuno, S.; Takamatsu, J.; Kamiya, T. 1993: Effect of substrate and diluent for factor VIIi activity in highly purified factor VIIi concentrate and patient plasma infused factor VIIi concentrate Rinsho Byori. Japanese Journal of Clinical Pathology 41(7): 825-830
Muntean, W. 1984: Purified complex of factor VIII coagulant moiety and phospholipid: high factor VIII coagulant activity in factor VIII inhibitor plasma Wiener Klinische Wochenschrift 96(22): 829-832
Feinmann, J. 1986: The manifesto mystery Nursing Times 82(41): 17-18
Gamber, R.; Holland, S.; Russo, D.P.; Cruser, d.Anges.; Hilsenrath, P.E. 2005: Cost-effective osteopathic manipulative medicine: a literature review of cost-effectiveness analyses for osteopathic manipulative treatment Journal of the American Osteopathic Association 105(8): 357-367
Middleton, J. 2015: "Why should nurses fund manifesto pledge"? Nursing Times 111(17): 1
Fijnvandraat, K.; Berntorp, E.; ten Cate, J.W.; Johnsson, H.; Peters, M.; Savidge, G.; Tengborn, L.; Spira, J.; Stahl, C. 1997: Recombinant, B-domain deleted factor VIII (r-VIII SQ): pharmacokinetics and initial safety aspects in hemophilia A patients Thrombosis and Haemostasis 77(2): 298-302
Jaya Kumar, S. 2000: Population and environment by 2000 AD : A social manifesto International Journal of Sociology and Social Policy 20(8): 55-68
Camenzind, M. 2012: Manifesto for health workforce crisis. Against the fatal "care drain" Krankenpflege. Soins Infirmiers 105(3): 13-14; 46-7; 70-71
Fryns, J.P.; Devriendt, K.; Detroch, C.; Decock, P. 1998: Distinct familial syndrome of severe to profound mental retardation, spastic paraplegia with contrasting axial hypotonia, short stature and distinct craniofacial appearance with nasal hypoplasia Genetic Counseling 9(1): 51-54
Liebe, S. 1982: Activation of the antihemophilic globulin a (factor VIII). 2. Effect of ampholine on the course of blood coagulation and the molecular conformation of factor VIIi Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 37(4): 110-116
Teitel, J.M.; Lau, H.K.; Garvey, M.B. 2002: Discrepancies in measured factor VIIi activity in patients treated with factor VIIi concentrate of human or porcine origin Thrombosis and Haemostasis 88(1): 159-160
Brettler, D.B.; Forsberg, A.D.; Levine, P.H.; Aledort, L.M.; Hilgartner, M.W.; Kasper, C.K.; Lusher, J.M.; McMillan, C.; Roberts, H. 1989: The use of porcine factor VIII concentrate (Hyate:C) in the treatment of patients with inhibitor antibodies to factor VIII. A multicenter US experience Archives of Internal Medicine 149(6): 1381-1385